Moreover, considering the individual signaling variability previously evidenced in CLL B-lymphocytes isolated from different patients [13], it was important to verify whether the regulatory relationship between JAK2 and RhoA observed in normal B-lymphocytes was also conserved in CLL B-lymphocytes. Here, JAK2 is linked to B-cell chronic lymphocytic leukemia.